You Are Here: Home > Researchers > Patient Engagement > Study Recruitment

Study Recruitment

Study Recruitment

Through studies such as these, arthritis will be better understood and new and improved approaches to management will be identified and implemented. We hope to:

  • link you with Canadian researchers who are using the Internet, telephone or mail to conduct national arthritis research;
  • provide you with opportunities to participate in research studies in your geographic region, if available
  • provide an opportunity for people with arthritis from across Canada to be able to participate in arthritis research from the comfort of their homes.

Please note: The research studies listed on this site have received ethics committee approval. The opportunities posted here do not include clinical trials.

How can I submit my study?

Download the Patient Study Checklist [PDF] and submit it to research@arthritis.ca / 1.800. 321.1433. Please note that we will not post opportunities that do not meet the criteria set out in our policy.

Current Studies

  • Preferences for the non-surgical management of osteoarthritis

    Investigators:
    Dr. Deborah Marshall
    Dr. Gillian Currie

    Research host institution:
    University of Calgary

    Background:
    By 2040, 25% of Canadians will have osteoarthritis. Many factors affect how people take care of their
    osteoarthritis. It is important to understand what matters to patients when designing programs to help
    patients manage their osteoarthritis.

    Purpose of the study:
    The purpose of the study is to get an in-depth understanding of what matters to people in taking care of
    their osteoarthritis. It will also explore who and what people believe influences their osteoarthritis.

    Eligibility:
    Individuals are eligible to participate if they are from Alberta and have been told by their doctor that
    have knee and/or hip osteoarthritis, and have at least one joint that has not undergone replacement
    surgery. Participants must be 18 years of age or older, and be able to communicate in English.

    Participation details:
    Participants will take part in a one-hour online or telephone interview about their experiences taking
    care of their osteoarthritis, and complete a brief online survey prior to that. Participants will receive a
    $10 gift card in thanks for their participation.

    Confidentiality protocols:
    Information collected as part of this research project will be kept confidential and will be protected at all
    times during and after the study. It will only be accessed by the research team members for research
    purposes.

    Geographic location:
    Alberta, Canada

    Recruitment start and end date:
    Recruitment for the study began on December 17, 2020 and is anticipated to continue until June 2021.

    For more information:
    Please contact the study coordinator at Bryanne.kennedy@ucalgary.ca or (403) 441-3655

    This research has been approved by the University of Calgary Conjoint Health Research Ethics Board
    REB20-0671.

  • Promoting engagement in physical activity among young people with juvenile idiopathic arthritis: Development of a social network-based intervention

    Researchers: Sabrina Cavallo Ph.D., Dr Ciarán Duffy, Jennifer Stinson, Ph.D., Karine April Toupin, Ph.D.  

    Institution: Université de Montréal et Centre de recherche interdisciplinaire en réadaptation du Montréal Métropolitain (CRIR)

    We would like to get the opinion of young people living with juvenile idiopathic arthritis (JIA) on JIActiv, a social media-based group intervention aimed at promoting physical activity.

    To participate in the study, young people need to meet the following criteria:
    1) Be between 13 and 25 years of age,
    2) Have been diagnosed with JIA by a paediatric rheumatologist,
    3) Understand and be able to express themselves in English or French,
    4) Have an e-mail address or create one for the purpose of the study;
    5) Have access to an electronic device giving access to the internet.

    Participation in the study involves two one-hour interviews with the young person as well as filling out a questionnaire that will take about 15-min. Young people who are interviewed will be compensated for their participation in the form of gift certificates that will be mailed to them after each interview.

    We would also like to get the opinion of parents of young people with juvenile idiopathic arthritis (JIA) on JIActiv, a social media-based group intervention aimed at promoting physical activity.

    To participate in the study, parents need to meet the following criteria:
    1) Have at least one child aged between 13 and 25 years who lives with JIA,
    2) Understand and be able to express themselves in English or French,
    3) Have an e-mail address or create one for the purpose of the study;
    4) Have access to an electronic device giving access to the internet.

    Participation in the study involves two one-hour interviews with the parent as well as filling out a questionnaire that will take about 15-min. Parents who are interviewed will be compensated for their participation in the form of gift certificates that will be mailed to them after each interview.

    Interviews will be anonymized to maintain participant confidentiality. All research data will be kept on a secured server of the Institut universitaire sur la réadaptation en déficience physique de Montréal (IURDPM) and all files will be password protected.

    If you are interested, please contact Sabrina Cavallo, researcher at the University of Montreal, at 514-343-7217 or by Email at sabrina.cavallo@umontreal.ca.

  • Understanding the experiences of individuals with rheumatic diseases during the COVID-19 pandemic (UNIFIED)

    Investigators:
    Dr. Mary De Vera
    Dr. Antonio Avina-Zubieta
    Dr. Kam Shojania

    Research host institution:
    University of British Columbia/Arthritis Research Canada

    Background:
    The COVID-19 pandemic has brought tremendous challenges for people living with arthritis who are vulnerable to infections yet need complex, continual care. It is important to understand patients’ experiences during this time to inform best practices and optimize care.

    Purpose of the study:
    To understand the impacts of the COVID-19 pandemic on patients with arthritis, specifically on: a) rheumatic disease treatment (e.g. treatment delays); b) mental health and psychosocial factors; and c) activities of daily living (e.g. self-care).

    Eligibility: 
    Individuals are eligible to participate if they: are 18 years or older; have been diagnosed with a rheumatic disease (e.g. ankylosing spondylitis, gout, juvenile idiopathic arthritis, osteoarthritis, psoriatic arthritis, rheumatoid arthritis, systemic lupus erythematosus); and are able to communicate in English or French.

    Participation details:
    Participants will be asked to complete an online survey (in English or French) which takes approximately 25 minutes. There are no known risks to participating.  

    Confidentiality protocols:
    The survey is hosted on Qualtrics, a Canadian survey platform, which fully complies with the British Columbia Freedom of Information and Protection of Privacy Act.   Survey responses are encrypted and stored on a secure server at the University of British Columbia.

    Geographic location: This is an international survey

    Recruitment start and end date:
    Recruitment for the study began on April 23, 2020.  We anticipate to recruit for at least 1 year.

    For more information:
    Please contact the study coordinator at louisega@mail.ubc.ca or (604) 822-5697

    This study has been approved either by the full Behavioural REB or by an authorized delegated reviewer.

  • Inside Trials - An interview of clinical trials and clinical reporting

    Researchers are inviting individuals with arthritis who have previously taken part in a clinical trial of a prescription drug to participate in an interview study to share their experiences of taking part in a trial.

    Why participate in this study? Patients play a key role in research as participants in clinical trials and learning about trials from the patient perspective is important for improving arthritis research. We are interested to learn more about the experiences and views of people who have taken part in a clinical trial. As part of the study, we would like to find out how trial participants view the importance of publishing the results of trial research.

    Those who can take part in the study have:

    • Participated in a clinical trial of a prescription drug prior to the last 12 months and within the last 5 years,
    • participated in the trial as a patient with arthritis or another health condition (rather than as a “healthy volunteer”), and 
    • were 18 years or older when participating in the trial.

    Participating in this study would involve taking part in an interview of about 60 minutes and possibly a 30-minute follow-up interview. Interviews will be held in Victoria and Vancouver. In order to acknowledge the time taken to participate in this project, each participant will receive an honorarium of $50. 

    Additional information about the study: The study will also involve interviews with clinical trial investigators, university administrators, research ethics board members and individuals who have participated in other types of clinical drug trials to provide additional perspectives on clinical trials and trial reporting. The closing date of the project is August 31, 2021.

    Contact Details: Those interested in participating or finding out more information can contact Co-Investigator Richard Morrow at rlmorrow@mail.ubc.ca or visit www.insidetrialsstudy.ca

    This study received ethics approval (#H18-03458) through the University of British Columbia
    Behavioural Research Ethics Board.

  • YAWNS NB – Your Answers While Needing Sleep in New Brunswick

    Names of Investigators on the Team:
    Dr. David Gardner (project lead), Dalhousie University
    Dr. Andrea Murphy (co-lead), Dalhousie University
    Dr. Justin Turner (co-investigator), Université de Montréal
    Dr. Margaret Radja (co-investigator), Dalhousie University
    Dr. Sandra Magalhaes (co-investigator), University of New Brunswick

    Research Host Institution:
    Dalhousie University

    Background:
    The most common approach to managing insomnia is to take sleeping pills. This approach is associated with a high risk for falls, bone fractures and other injuries, drug interactions with pain medications and others. Less well known is a type of sleep therapy known as Cognitive Behavioural Therapy for Insomnia (CBTi). In the past, CBTi was available from psychologists and other trained therapists only. Now, there are new ways to get access to CBTi, including self-guided books, apps for your phone, and online services. In the short-term, CBTi is as effective as sleeping pills without the risk of serious side effects, and in the long-term it is the more effective and safer option. Older adults living in New Brunswick have a high rate of use of sleeping pills compared to the rest of Canada. It is important that they learn about the safer option - CBTi.

    Purpose of the study:
    Our study aims to measure the impact of sharing information about different options for managing insomnia using mailed information packages. 

    Eligibility Criteria:
    1) 65 years of age and older
    2) taking sleeping pills
    3) living in New Brunswick
    4) comfortable with communicating in English

    Participation Details (including time commitment and possible risks):
    There is no travel required. Participation will be done by telephone. After enrolling, participants will engage in 2 telephone interviews that will be conducted 6 months apart. Each interview is expected to take 60-90 minutes.

    Learn more/contact research team:
    Call: 1 844 929 6762
    Email: YAWNS@dal.ca
    Web: https://sleepstudy.ca  

    Confidentiality Protocols:
    Participants will provide informed consent to be eligible to participate. Collected research data will be stored on a secure, encrypted server of Dalhousie University. The final dataset will be completely de-identified.  

    Geographic Location:
    This study will involve people living in New Brunswick.

    Recruitment Start and End Date:
    Recruitment for this study will take place between November 2020 – September 2021.

    This study received approval from the Health Sciences Research Ethics Board. REB #: 2020-5184.